Trulieve Cannabis (TRLV) Accumulated Expenses (2020 - 2022)

Trulieve Cannabis has reported Accumulated Expenses for 3 years, with the latest figure at $19.5 million in Q4 2022.

• On a quarterly basis, Accumulated Expenses fell 20.95% year-over-year to $19.5 million in Q4 2022; TTM through Dec 2022 was $19.5 million, a 20.95% decrease from a year earlier, with the FY2022 full-year figure at $19.5 million, down 20.95% from the prior year.
• Accumulated Expenses was $19.5 million for Q4 2022 at Trulieve Cannabis, down from $27.2 million in the prior quarter.
• The five-year high for Accumulated Expenses was $27.2 million in Q1 2022, with the low at $11.0 million in Q4 2020.
• Average Accumulated Expenses over 3 years is $20.6 million, with a median of $22.1 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Accumulated Expenses soared 124.19% in 2021, then dropped 20.95% in 2022.
• Over 3 years, Accumulated Expenses stood at $11.0 million in 2020, then jumped by 124.19% to $24.7 million in 2021, then decreased by 20.95% to $19.5 million in 2022.
• The last three Accumulated Expenses figures came in at $19.5 million (Q4 2022), $27.2 million (Q1 2022), and $24.7 million (Q4 2021), per Business Quant data.